Pharmawire's unique benefits:

• Market Leading - An average of six months ahead of an event
• Proprietary - Articles generated in-house and read only by Pharmawire users
• Material - All coverage on events considered material (>=20% revenue stream for company)
• Unbiased - There are no financial conflicts of interest for Pharmawire
• Expert Opinion - Our sources include KOLs, investigators, doctors, lawyers, investment bankers, and C-level management at corporates
• Well-Vetted - We rely on multiple and varied sources that are screened and interviewed
• Transparent - Intention, sources, business model
• Accessible - We encourage open dialogue and queries with Pharmawire’s investigative reporters
• Proactive - Intelligence on upcoming material events is pushed to you in real time via direct email

With global access to important decision makers and experts, Pharmawire journalists provide forward looking insight that can only be found in BioPharm Insight through the Pharmawire service.